Loading the records…
Loading the records…
HR11013, introduced in the 119th Congress, amends the Public Health Service Act to protect the integrity of the U.S. Preventive Services Task Force. The bill is in early stage, referred to the House Committee on Energy and Commerce, with no direct market impact expected at this stage.
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
The bill does not directly affect any specific company's revenue or competitive position. Investors should focus on broader healthcare policy trends, such as preventive care coverage mandates, rather than this isolated bill. No real market data is available to assess price movements.
On November 12, 2026, Rep. Maxine Dexter (D-OR) introduced HR11013, a bill to amend the Public Health Service Act to protect the integrity of the United States Preventive Services Task Force (USPSTF). The bill was referred to the House Committee on Energy and Commerce and has two original cosponsors, both Democrats. The USPSTF is an independent body that issues evidence-based recommendations on preventive health services, which influence coverage requirements under the Affordable Care Act. This bill appears designed to safeguard the task force's independence from political interference, but its specific mechanisms are not detailed in the available text.
The bill does not authorize or appropriate any funding. It is a policy-only measure that would codify protections for the task force's operations. Without a funding component, there is no direct financial allocation to any government program or private entity. The legislative path requires committee markup, House passage, Senate consideration, and presidential action. Given the early stage and lack of bipartisan sponsorship, passage is uncertain and likely distant.
No related signals or procurement data were provided for convergence analysis. The bill stands alone as a procedural healthcare policy measure. Its impact on the healthcare sector is minimal at this point, as it does not change any existing coverage requirements or reimbursement rates. The primary effect, if enacted, would be to maintain the status quo of evidence-based preventive care recommendations, which could provide regulatory stability for insurers and providers.
Structural winners and losers are not identifiable without more specific provisions. The bill does not target any particular company or industry segment. Investors should monitor committee activity for amendments that could introduce substantive changes, such as altering which services the task force reviews or how its recommendations are implemented. Currently, no publicly traded company faces a direct revenue impact from this bill.
The timeline for HR11013 is uncertain. As a referred bill in the 119th Congress, it must clear the Energy and Commerce Committee, pass the House, and navigate the Senate. Given the divided government and the bill's narrow focus, it may not advance significantly in the current session. Investors should treat this as a low-priority legislative signal.
Matched on shared policy language across AI analyses, with ticker & timing weight
MERCK SHARP & DOHME LLC: $1.8B Department of Health and Human Services Contract Vehicle
OHIO DEPARTMENT OF MEDICAID: $28.2B Department of Health and Human Services Grant
MULTIPLE RECIPIENTS: $1.2B Department of Health and Human Services Federal Award
MULTIPLE RECIPIENTS: $2.1B Department of Health and Human Services Federal Award
MULTIPLE RECIPIENTS: $4.6B Department of Health and Human Services Federal Award
MULTIPLE RECIPIENTS: $4.6B Department of Health and Human Services Federal Award
MULTIPLE RECIPIENTS: $4.0B Department of Health and Human Services Federal Award
MULTIPLE RECIPIENTS: $1.4B Department of Health and Human Services Federal Award
Executive orders & memoranda affecting the same sectors or companies
This executive order establishes a Women's Health Division within the NIH to coordinate and accelerate research on understudied women's health conditions, and creates a White House Women's Health Task Force to drive policy reforms and translation of research into clinical practice across federal agencies. It directs specific agencies to prioritize research, data collection, and translation into prevention, diagnosis, and treatment, with a focus on all life stages from infancy through aging.
This executive order directs the Secretaries of State, Labor, and Homeland Security to coordinate with Commerce, Education, and the SBA when processing H-1B petitions, and requires them to consider whether the employer has engaged in layoffs of similarly situated U.S. workers within the past year. It also orders the Labor Department to review past labor condition applications for potential enforcement actions against sponsoring employers, effectively tightening scrutiny on H-1B usage, especially by outsourcing firms.
This proclamation orders the Secretaries of War and Veterans Affairs to mandate rapid, ongoing digital sharing of military personnel and medical records, deploy AI-powered tools for benefits applications, and update existing IT contracts for interoperability. It also requires the Transition Assistance Program to connect separating service members to specific jobs or training programs before discharge.
Free — no credit card
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →